Interleukin-17A Antagonist [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Interleukin-17A Antagonist [EPC] includes 2 drugs with a combined 184,903 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
184,903
Combined Reports
All Interleukin-17A Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| SECUKINUMAB | COSENTYX | 151,223 | 6,855 | 19,098 | 4.5% |
| IXEKIZUMAB | TALTZ | 33,680 | 470 | 2,424 | 1.4% |
Common Side Effects in Interleukin-17A Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 30,193 | 1,310 |
| Psoriasis | 24,794 | 453 |
| Pain | 15,900 | 1,660 |
| Arthralgia | 14,483 | 1,653 |
| Fatigue | 9,928 | 1,797 |
| Psoriatic arthropathy | 9,453 | 1,851 |
| Pruritus | 9,391 | 1,090 |
| Malaise | 9,053 | 1,595 |
| Rash | 8,740 | 1,815 |
| Condition aggravated | 7,912 | 1,527 |